Equities researchers at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research report issued on Tuesday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
AMPE stock opened at $0.00 on Tuesday. The company has a market capitalization of $681.00, a price-to-earnings ratio of 0.00 and a beta of 3.77. Ampio Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $1.05.
Ampio Pharmaceuticals Company Profile
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- What Investors Need to Know About Upcoming IPOs
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Are Tariffs Threatening Disney’s Comeback Story?
- Earnings Per Share Calculator: How to Calculate EPS
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
